Cargando…
Autologous Stem Cell Transplantation in Multiple Myeloma with Renal Failure: Friend or Foe?
Autologous stem cell transplantation (ASCT) is a standard treatment for multiple myeloma (MM), but the clinical response and renal curative effect in MM patients with renal failure (RF) remain controversial. The myeloma kidney disease has different types, and most are due to the direct toxic effects...
Autores principales: | Zhong, Hongfei, Xie, Xiaojie, Xu, Gaosi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875020/ https://www.ncbi.nlm.nih.gov/pubmed/31781250 http://dx.doi.org/10.1155/2019/9401717 |
Ejemplares similares
-
The Immune Microenvironment in Multiple Myeloma: Friend or Foe?
por: Lopes, Raquel, et al.
Publicado: (2021) -
Influence of gut microbiome on multiple myeloma: friend or foe?
por: Ahmed, Nausheen, et al.
Publicado: (2020) -
Sequential, Autologous Hematopoietic Stem Cell Transplant Followed by Renal Transplant in Multiple Myeloma
por: Bhowmik, D., et al.
Publicado: (2017) -
Hyperkalemia in heart failure: Foe or friend?
por: Rakisheva, Amina, et al.
Publicado: (2020) -
Current status of autologous stem cell transplantation for multiple myeloma
por: Al Hamed, Rama, et al.
Publicado: (2019)